Talkiatry IPO
Talkiatry is a mental health platform focused specifically on psychiatry services, connecting patients with psychiatrists for medication management and treatment of mental health conditions. The company differentiates itself by focusing solely on psychiatric care rather than broader mental health services. Investors are interested in its specialized approach to addressing the shortage of accessible psychiatric care.
Key Facts
| Industry | Digital Mental Health |
| Founded | 2020 |
| Headquarters | New York, NY |
| Employees | ~500 |
| Website | talkiatry.com |
| Funding | Series B funding. Total raised: $130M |
About Talkiatry
Talkiatry operates a specialized telepsychiatry platform that connects patients with board-certified psychiatrists for medication management and psychiatric care. Unlike therapy-focused platforms, Talkiatry specifically addresses the shortage of psychiatric providers by offering comprehensive psychiatric evaluations, medication management, and ongoing care through video consultations.
The company has built a network of full-time employed psychiatrists rather than relying on contractors, ensuring consistent care quality and availability. Talkiatry accepts most major insurance plans and has expanded across multiple states, addressing critical gaps in mental healthcare access particularly for patients requiring psychiatric medication management for conditions like depression, anxiety, ADHD, and bipolar disorder.
IPO Status
Talkiatry has not announced any IPO plans and continues operating as a private company. The psychiatry-focused telehealth platform has raised venture funding to expand its network of psychiatrists and geographic coverage. The company has been growing its operations while focusing on its specialized psychiatric services model. There have been no public reports or rumors about IPO preparations for Talkiatry. As a more specialized player in the mental health space compared to broader platforms, the company appears to be focused on scaling its operations and building its provider network. Given the regulatory scrutiny that has affected some mental health platforms, companies in this sector are likely being more cautious about public market timing.
Competitors
Frequently Asked Questions
Does Talkiatry have a stock?
No, Talkiatry has not had an IPO and remains a private company. The psychiatry platform has not announced any plans for going public.
When is the Talkiatry IPO date?
Talkiatry has not announced an IPO date, and there are no confirmed details about potential public offering timeline.
How can I buy Talkiatry stock?
You cannot currently buy Talkiatry stock as it is privately held. Shares would only become available to retail investors following a potential IPO.
Stay Updated on the Talkiatry IPO
Get real-time alerts when Talkiatry files for an IPO, prices shares, or begins trading.
Get IPO Alerts